Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 26, Issue 4, Pages 172-175Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2005.02.003
Keywords
-
Categories
Ask authors/readers for more resources
Intestinal infection with Vibrio cholerae results in secretory diarrhea with potentially massive fluid losses and volume depletion. Morbidity and mortality associated with cholera remain a major problem in the developing world despite the success of oral rehydration therapy. New research aiming to inhibit cholera toxin binding to receptors in the intestine provides an attractive strategy for cholera therapy. Together with anti-secretory agents, including inhibitors of enkephalinase and of the cystic fibrosis transmembrane conductance regulator, new treatment options for managing severe diarrhea in cholera could soon be available,
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available